FDA NEWS

Eli Lilly submits supplemental new drug application for Cymbalta - CNBC
NEW YORK (Thomson Financial) - Eli Lilly and Co. Thursday said it submitted a supplemental new drug application to the Food and Drug Administration for a new version of its drug Cymbalta, which treats depressive disorder and diabetic peripheral
Source: www.cnbc.com

New Drug Eases Severe Constipation - NewsMax.com
An experimental once-a-day pill offered relief to nearly half the people with severe, long-term constipation, researchers reported on Wednesday. The drug prucalopride, which Belgium-based Movetis NV plans to market in Europe under the brand name
Source: www.newsmax.com

Eli Lilly asks FDA to expand approved Cymbalta use - Forbes
Drug developer Eli Lilly and Co. said Thursday it asked the Food and Drug Administration to approve its depression drug Cymbalta as a chronic pain treatment. The company said its filing with the FDA is based on studies conducted in patients with
Source: www.forbes.com

Ligand shares fall 34% on FDA report - San Diego Union-Tribune
Shares of Ligand Pharmaceuticals plunged 34 percent after federal drug regulators released documents that indicate they do not favor approving the company's experimental blood disorder drug, Promacta. The Food and Drug Administration in effect called
Source: www.signonsandiego.com

Wyeth:FDA Fast Track For Pediatric Pneumococcal Vaccine - CNN Money
Wyeth's (WYE) division, Wyeth Pharmaceuticals, said the Food and Drug Administration granted fast track designation to its investigational 13-valent pneumococcal conjugate vaccine for infants and toddlers. The company is seeking a pediatric
Source: money.cnn.com

UPDATE 1-Glaxo seeks U.S. approval for anti-nausea drug - Reuters
LONDON, May 29 (Reuters) - GlaxoSmithKline Plc (GSK.L: Quote , Profile , Research ) said on Thursday it had submitted its new anti-nausea drug Rezonic for approval in the United States, and presented fresh clinical data supporting the medicine's
Source: www.reuters.com

Glaxo seeks FDA approval for anti-vomiting drug - Forbes
GlaxoSmithKline PLC said Thursday it submitted an application to the Food and Drug Administration to approve a drug to treat nausea and vomiting associated with chemotherapy. The U.K.-based drug maker said its application is supported by two late
Source: www.forbes.com

Lilly Submits Cymbalta(R) Supplemental New Drug Application for - MSN MoneyCentral
Eli Lilly and Company (NYSE: LLY) has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval for a new indication for Cymbalta® (duloxetine HCl) for the management of chronic pain, the
Source: news.moneycentral.msn.com